The Journal of Immunology, Vol 155, Issue 12 5543-5549, Copyright © 1995 by American Association of Immunologists

ARTICLES

Cross-linking of the Fas/APO-1 antigen suppresses the CD3-mediated signal transduction events in human T lymphocytes

B Kovacs and GC Tsokos
Department of Clinical Investigation, Walter Reed Army Medical Center, Washington, DC 20307-5001, USA.

The Fas/APO-1 Ag, a member of the TNF-R family, mediates apoptosis (programmed cell death, PCD). PCD has been recognized to be important in the regulation of normal and autoimmune responses. However, the underlying molecular mechanisms are not fully known. To elucidate the role of the Fas Ag in lymphocyte activation, we investigated the influence of Fas Ag cross-linking on CD3/TCR-mediated signal transduction in IL-2-dependent human T cell lines. Early signal transduction events were evaluated in 10-day-old T cell lines using anti-Fas and anti-CD3 mAbs. Incubation of Indo-1-loaded cells with anti- Fas mAb (10 micrograms/ml), but not with an isotypic control mAb almost completely inhibited the anti-CD3-mediated Ca2+ influx. This inhibition was mAb concentration dependent and was detected after incubation for at least 15 min. Cross-linking of the Fas Ag did not affect the anti- CD3-mediated release of Ca2+ from the internal stores or the thapsigargin-mediated Ca2+ influx. Anti-Fas mAb-incubated cells also showed decreased CD3-mediated inositol 1,4,5-trisphosphate production. Preincubation of cells with anti-Fas mAb inhibited the anti-CD3- mediated tyrosine phosphorylation of multiple cellular proteins. Cross- linking of the Fas Ag for up to 6 h did not alter the expression of CD3 on the surface of the T cells. Preincubation of Indo-1-loaded EBV- transformed B cells with anti-Fas mAb did not affect the anti-mu Ab- induced increase in intracellular calcium ([Ca2+]i). Our results show that cross-linking of the Fas Ag can suppress the receptor-mediated signaling process in human T but not B cells.

This article has been cited by other articles:

				G. V. Denis, Q. Yu, P. Ma, L. Deeds, D. V. Faller, and C.-Y. Chen Bcl-2, via Its BH4 Domain, Blocks Apoptotic Signaling Mediated by Mitochondrial Ras J. Biol. Chem., February 14, 2003; 278(8): 5775 - 5785. [Abstract] [Full Text] [PDF]

				M. K. Sharief and Y. K. Semra Down-Regulation of Survivin Expression in T Lymphocytes After Interferon Beta-1a Treatment in Patients With Multiple Sclerosis Arch Neurol, July 1, 2002; 59(7): 1115 - 1121. [Abstract] [Full Text] [PDF]

				I. Medana, Z. Li, A. Flugel, J. Tschopp, H. Wekerle, and H. Neumann Fas Ligand (CD95L) Protects Neurons Against Perforin- Mediated T Lymphocyte Cytotoxicity J. Immunol., July 15, 2001; 167(2): 674 - 681. [Abstract] [Full Text] [PDF]

				T. M. Yankee, K. E. Draves, M. K. Ewings, E. A. Clark, and J. D. Graves CD95/Fas induces cleavage of the GrpL/Gads adaptor and desensitization of antigen receptor signaling PNAS, June 5, 2001; 98(12): 6789 - 6793. [Abstract] [Full Text] [PDF]

				A. Lepple-Wienhues, C. Belka, T. Laun, A. Jekle, B. Walter, U. Wieland, M. Welz, L. Heil, J. Kun, G. Busch, et al. Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids PNAS, November 23, 1999; 96(24): 13795 - 13800. [Abstract] [Full Text] [PDF]

				C.-Y. Chen and D. V. Faller Selective Inhibition of Protein Kinase C Isozymes by Fas Ligation J. Biol. Chem., May 28, 1999; 274(22): 15320 - 15328. [Abstract] [Full Text] [PDF]

				M. Fleck, T. Zhou, T. Tatsuta, P. Yang, Z. Wang, and J. D. Mountz Fas/Fas Ligand Signaling During Gestational T Cell Development J. Immunol., April 15, 1998; 160(8): 3766 - 3775. [Abstract] [Full Text] [PDF]

				J. L. Gommerman and S. A. Berger Protection From Apoptosis by Steel Factor But Not Interleukin-3 Is Reversed Through Blockade of Calcium Influx Blood, March 15, 1998; 91(6): 1891 - 1900. [Abstract] [Full Text] [PDF]